Jeff Yass’s Jade Biosciences JBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$370K Buy
26,338
+13,195
+100% +$265K ﹤0.01% 10470
2026
Q2
$292K Sell
13,143
-5,165
-28% -$108K ﹤0.01% 11102
2026
Q1
$257K Buy
+18,308
New +$265K ﹤0.01% 11207
2025
Q4
– Sell
-17,653
Closed -$207K – 12320
2025
Q3
$152K Sell
17,653
-21,576
-55% -$176K ﹤0.01% 11265
2025
Q2
$392K Buy
39,229
+38,122
+3,444% +$1.3M ﹤0.01% 9739
2025
Q1
$97.3K Sell
1,107
-543
-33% -$47.7K ﹤0.01% 11558
2024
Q4
$153K Buy
+1,650
New +$142K ﹤0.01% 11003
2024
Q3
– Sell
-2,039
Closed -$132K – 11943
2024
Q2
$118K Buy
+2,039
New +$1.35M ﹤0.01% 10896
2022
Q1
– Sell
-451
Closed -$186K – 12949
2021
Q4
$186K Buy
+451
New +$228K ﹤0.01% 11526

Other funds holding JBIO

Jeff Yass's JBIO Position: Q3 2026 in Review

Jeff Yass increased its Jade Biosciences (JBIO) stake by 100% in Q3 2026, buying an estimated $265K and bringing the position to 26,338 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #10470.

Jeff Yass first reported a position in JBIO in Q4 2021 and has held it in 9 quarters since. The position peaked at $392K in Q2 2025. 160 funds tracked by Wall St. Rank hold JBIO as of Q3 2026.

  • Jeff Yass held 26,338 shares of Jade Biosciences worth $370K as of Q3 2026.
  • Jeff Yass bought 13,195 Jade Biosciences shares in Q3 2026, an estimated $265K.
  • Jade Biosciences made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #10470 holding.
  • Jeff Yass first reported a position in Jade Biosciences in Q4 2021 and has held it in 9 quarters since.
  • Jeff Yass's Jade Biosciences position peaked at $392K in Q2 2025.
  • 160 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.